Global and South Korea Rofecoxib Market Analysis 2022: Industry Size, Share, Emerging Trends, Growth Opportunities And Forecast To 2028
| Price : US$ 3,000 | Date : Mar 2022 |
| Category : Healthcare and Pharmaceuticals | Pages : 110 |
Rofecoxib Market 2020 By Manufacturers, Regions, Types, Applications And Forecast To 2026
- Code : SMI27439
- Pages : 115
- Date : Aug, 2020
- Category : Services
- Publisher : SMI
- Format :
Summary
The global Rofecoxib Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Rofecoxib Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Rofecoxib Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Merck
- Chengdu Meinkai Chemical Co. LTD
- Wuhan Xinxin Jiali Biotechnology Co. LTD
- Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
- Pfizer
- Tremeau
- ...
By the Product Type, the market is primarily segmented into:
- Oral Suspension.
- Tablet-Form
By Applications, the market is segmented into:
- Osteoarthritis
- Rheumatoid Arthritis
- Juvenile Rheumatoid Arthritis
- Acute Pain Conditions
- Migraine
- Dysmenorrhea
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Brazil
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Rofecoxib Market Report:
- To assess the size of the market by value and volume
- Analyze the Rofecoxib Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Rofecoxib Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Rofecoxib Market
The Rofecoxib Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Rofecoxib Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1 Study Coverage
1.1 Rofecoxib Product Introduction
1.2 Market Segments
1.3 Key Rofecoxib Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rofecoxib Market Size Growth Rate by Type
1.4.2 Oral Suspension.
1.4.3 Tablet-Form
1.5 Market by Application
1.5.1 Global Rofecoxib Market Size Growth Rate by Application
1.5.2 Osteoarthritis
1.5.3 Rheumatoid Arthritis
1.5.4 Juvenile Rheumatoid Arthritis
1.5.5 Acute Pain Conditions
1.5.6 Migraine
1.5.7 Dysmenorrhea
1.6 Coronavirus Disease 2019 (Covid-19): Rofecoxib Industry Impact
1.6.1 How the Covid-19 is Affecting the Rofecoxib Industry
1.6.1.1 Rofecoxib Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Rofecoxib Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Rofecoxib Market Size Estimates and Forecasts
2.1.1 Global Rofecoxib Revenue 2015-2026
2.1.2 Global Rofecoxib Sales 2015-2026
2.2 Rofecoxib Market Size by Region: 2020 Versus 2026
2.2.1 Global Rofecoxib Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Rofecoxib Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rofecoxib Competitor Landscape by Players
3.1 Rofecoxib Sales by Manufacturers
3.1.1 Rofecoxib Sales by Manufacturers (2015-2020)
3.1.2 Rofecoxib Sales Market Share by Manufacturers (2015-2020)
3.2 Rofecoxib Revenue by Manufacturers
3.2.1 Rofecoxib Revenue by Manufacturers (2015-2020)
3.2.2 Rofecoxib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rofecoxib Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rofecoxib Revenue in 2019
3.2.5 Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Rofecoxib Price by Manufacturers
3.4 Rofecoxib Manufacturing Base Distribution, Product Types
3.4.1 Rofecoxib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rofecoxib Product Type
3.4.3 Date of International Manufacturers Enter into Rofecoxib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Rofecoxib Market Size by Type (2015-2020)
4.1.1 Global Rofecoxib Sales by Type (2015-2020)
4.1.2 Global Rofecoxib Revenue by Type (2015-2020)
4.1.3 Rofecoxib Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rofecoxib Market Size Forecast by Type (2021-2026)
4.2.1 Global Rofecoxib Sales Forecast by Type (2021-2026)
4.2.2 Global Rofecoxib Revenue Forecast by Type (2021-2026)
4.2.3 Rofecoxib Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rofecoxib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Rofecoxib Market Size by Application (2015-2020)
5.1.1 Global Rofecoxib Sales by Application (2015-2020)
5.1.2 Global Rofecoxib Revenue by Application (2015-2020)
5.1.3 Rofecoxib Price by Application (2015-2020)
5.2 Rofecoxib Market Size Forecast by Application (2021-2026)
5.2.1 Global Rofecoxib Sales Forecast by Application (2021-2026)
5.2.2 Global Rofecoxib Revenue Forecast by Application (2021-2026)
5.2.3 Global Rofecoxib Price Forecast by Application (2021-2026)
6 North America
6.1 North America Rofecoxib by Country
6.1.1 North America Rofecoxib Sales by Country
6.1.2 North America Rofecoxib Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Rofecoxib Market Facts & Figures by Type
6.3 North America Rofecoxib Market Facts & Figures by Application
7 Europe
7.1 Europe Rofecoxib by Country
7.1.1 Europe Rofecoxib Sales by Country
7.1.2 Europe Rofecoxib Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rofecoxib Market Facts & Figures by Type
7.3 Europe Rofecoxib Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Rofecoxib by Region
8.1.1 Asia Pacific Rofecoxib Sales by Region
8.1.2 Asia Pacific Rofecoxib Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Rofecoxib Market Facts & Figures by Type
8.3 Asia Pacific Rofecoxib Market Facts & Figures by Application
9 Latin America
9.1 Latin America Rofecoxib by Country
9.1.1 Latin America Rofecoxib Sales by Country
9.1.2 Latin America Rofecoxib Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Rofecoxib Market Facts & Figures by Type
9.3 Central & South America Rofecoxib Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Rofecoxib by Country
10.1.1 Middle East and Africa Rofecoxib Sales by Country
10.1.2 Middle East and Africa Rofecoxib Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Rofecoxib Market Facts & Figures by Type
10.3 Middle East and Africa Rofecoxib Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Rofecoxib Products Offered
11.1.5 Merck Recent Development
11.2 Chengdu Meinkai Chemical Co. LTD
11.2.1 Chengdu Meinkai Chemical Co. LTD Corporation Information
11.2.2 Chengdu Meinkai Chemical Co. LTD Description, Business Overview and Total Revenue
11.2.3 Chengdu Meinkai Chemical Co. LTD Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Products Offered
11.2.5 Chengdu Meinkai Chemical Co. LTD Recent Development
11.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
11.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
11.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Description, Business Overview and Total Revenue
11.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Products Offered
11.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
11.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
11.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
11.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description, Business Overview and Total Revenue
11.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Products Offered
11.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description, Business Overview and Total Revenue
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Rofecoxib Products Offered
11.5.5 Pfizer Recent Development
11.6 Tremeau
11.6.1 Tremeau Corporation Information
11.6.2 Tremeau Description, Business Overview and Total Revenue
11.6.3 Tremeau Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Tremeau Rofecoxib Products Offered
11.6.5 Tremeau Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Rofecoxib Products Offered
11.1.5 Merck Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Rofecoxib Market Estimates and Projections by Region
12.1.1 Global Rofecoxib Sales Forecast by Regions 2021-2026
12.1.2 Global Rofecoxib Revenue Forecast by Regions 2021-2026
12.2 North America Rofecoxib Market Size Forecast (2021-2026)
12.2.1 North America: Rofecoxib Sales Forecast (2021-2026)
12.2.2 North America: Rofecoxib Revenue Forecast (2021-2026)
12.2.3 North America: Rofecoxib Market Size Forecast by Country (2021-2026)
12.3 Europe Rofecoxib Market Size Forecast (2021-2026)
12.3.1 Europe: Rofecoxib Sales Forecast (2021-2026)
12.3.2 Europe: Rofecoxib Revenue Forecast (2021-2026)
12.3.3 Europe: Rofecoxib Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Rofecoxib Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Rofecoxib Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Rofecoxib Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Rofecoxib Market Size Forecast by Region (2021-2026)
12.5 Latin America Rofecoxib Market Size Forecast (2021-2026)
12.5.1 Latin America: Rofecoxib Sales Forecast (2021-2026)
12.5.2 Latin America: Rofecoxib Revenue Forecast (2021-2026)
12.5.3 Latin America: Rofecoxib Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Rofecoxib Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Rofecoxib Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Rofecoxib Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Rofecoxib Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porters Five Forces Analysis
13.5 Primary Interviews with Key Rofecoxib Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rofecoxib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Table
List of Tables
Table 1. Rofecoxib Market Segments
Table 2. Ranking of Global Top Rofecoxib Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rofecoxib Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Oral Suspension.
Table 5. Major Manufacturers of Tablet-Form
Table 6. COVID-19 Impact Global Market: (Four Rofecoxib Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Rofecoxib Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Rofecoxib Players to Combat Covid-19 Impact
Table 11. Global Rofecoxib Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Rofecoxib Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Rofecoxib Sales by Regions 2015-2020 (MT)
Table 14. Global Rofecoxib Sales Market Share by Regions (2015-2020)
Table 15. Global Rofecoxib Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Rofecoxib Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Rofecoxib Sales Share by Manufacturers (2015-2020)
Table 18. Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Rofecoxib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rofecoxib as of 2019)
Table 20. Rofecoxib Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Rofecoxib Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Rofecoxib Price (2015-2020) (USD/MT)
Table 23. Rofecoxib Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Rofecoxib Product Type
Table 25. Date of International Manufacturers Enter into Rofecoxib Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Rofecoxib Sales by Type (2015-2020) (MT)
Table 28. Global Rofecoxib Sales Share by Type (2015-2020)
Table 29. Global Rofecoxib Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Rofecoxib Revenue Share by Type (2015-2020)
Table 31. Rofecoxib Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Rofecoxib Sales by Application (2015-2020) (MT)
Table 33. Global Rofecoxib Sales Share by Application (2015-2020)
Table 34. North America Rofecoxib Sales by Country (2015-2020) (MT)
Table 35. North America Rofecoxib Sales Market Share by Country (2015-2020)
Table 36. North America Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Rofecoxib Revenue Market Share by Country (2015-2020)
Table 38. North America Rofecoxib Sales by Type (2015-2020) (MT)
Table 39. North America Rofecoxib Sales Market Share by Type (2015-2020)
Table 40. North America Rofecoxib Sales by Application (2015-2020) (MT)
Table 41. North America Rofecoxib Sales Market Share by Application (2015-2020)
Table 42. Europe Rofecoxib Sales by Country (2015-2020) (MT)
Table 43. Europe Rofecoxib Sales Market Share by Country (2015-2020)
Table 44. Europe Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Rofecoxib Revenue Market Share by Country (2015-2020)
Table 46. Europe Rofecoxib Sales by Type (2015-2020) (MT)
Table 47. Europe Rofecoxib Sales Market Share by Type (2015-2020)
Table 48. Europe Rofecoxib Sales by Application (2015-2020) (MT)
Table 49. Europe Rofecoxib Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Rofecoxib Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Rofecoxib Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Rofecoxib Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Rofecoxib Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Rofecoxib Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Rofecoxib Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Rofecoxib Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Rofecoxib Sales Market Share by Application (2015-2020)
Table 58. Latin America Rofecoxib Sales by Country (2015-2020) (MT)
Table 59. Latin America Rofecoxib Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Rofecoxib Revenue Market Share by Country (2015-2020)
Table 62. Latin America Rofecoxib Sales by Type (2015-2020) (MT)
Table 63. Latin America Rofecoxib Sales Market Share by Type (2015-2020)
Table 64. Latin America Rofecoxib Sales by Application (2015-2020) (MT)
Table 65. Latin America Rofecoxib Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Rofecoxib Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Rofecoxib Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Rofecoxib Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Rofecoxib Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Rofecoxib Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Rofecoxib Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Rofecoxib Sales Market Share by Application (2015-2020)
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Chengdu Meinkai Chemical Co. LTD Corporation Information
Table 80. Chengdu Meinkai Chemical Co. LTD Description and Major Businesses
Table 81. Chengdu Meinkai Chemical Co. LTD Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Chengdu Meinkai Chemical Co. LTD Product
Table 83. Chengdu Meinkai Chemical Co. LTD Recent Development
Table 84. Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
Table 85. Wuhan Xinxin Jiali Biotechnology Co. LTD Description and Major Businesses
Table 86. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Wuhan Xinxin Jiali Biotechnology Co. LTD Product
Table 88. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
Table 89. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
Table 90. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description and Major Businesses
Table 91. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Product
Table 93. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Major Businesses
Table 96. Pfizer Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Pfizer Product
Table 98. Pfizer Recent Development
Table 99. Tremeau Corporation Information
Table 100. Tremeau Description and Major Businesses
Table 101. Tremeau Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Tremeau Product
Table 103. Tremeau Recent Development
Table 104. Global Rofecoxib Sales Forecast by Regions (2021-2026) (MT)
Table 105. Global Rofecoxib Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Rofecoxib Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Rofecoxib Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Rofecoxib Sales Forecast by Country (2021-2026) (MT)
Table 109. North America: Rofecoxib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Rofecoxib Sales Forecast by Country (2021-2026) (MT)
Table 111. Europe: Rofecoxib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Rofecoxib Sales Forecast by Region (2021-2026) (MT)
Table 113. Asia Pacific: Rofecoxib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Rofecoxib Sales Forecast by Country (2021-2026) (MT)
Table 115. Latin America: Rofecoxib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Rofecoxib Sales Forecast by Country (2021-2026) (MT)
Table 117. Middle East and Africa: Rofecoxib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Rofecoxib Players
Table 122. Rofecoxib Customers List
Table 123. Rofecoxib Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Rofecoxib Product Picture
Figure 2. Global Rofecoxib Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Suspension. Product Picture
Figure 4. Tablet-Form Product Picture
Figure 5. Global Rofecoxib Sales Market Share by Application in 2020 & 2026
Figure 6. Osteoarthritis
Figure 7. Rheumatoid Arthritis
Figure 8. Juvenile Rheumatoid Arthritis
Figure 9. Acute Pain Conditions
Figure 10. Migraine
Figure 11. Dysmenorrhea
Figure 12. Rofecoxib Report Years Considered
Figure 13. Global Rofecoxib Market Size 2015-2026 (US$ Million)
Figure 14. Global Rofecoxib Sales 2015-2026 (MT)
Figure 15. Global Rofecoxib Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Rofecoxib Sales Market Share by Region (2015-2020)
Figure 17. Global Rofecoxib Sales Market Share by Region in 2019
Figure 18. Global Rofecoxib Revenue Market Share by Region (2015-2020)
Figure 19. Global Rofecoxib Revenue Market Share by Region in 2019
Figure 20. Global Rofecoxib Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Rofecoxib Revenue in 2019
Figure 22. Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Rofecoxib Sales Market Share by Type (2015-2020)
Figure 24. Global Rofecoxib Sales Market Share by Type in 2019
Figure 25. Global Rofecoxib Revenue Market Share by Type (2015-2020)
Figure 26. Global Rofecoxib Revenue Market Share by Type in 2019
Figure 27. Global Rofecoxib Market Share by Price Range (2015-2020)
Figure 28. Global Rofecoxib Sales Market Share by Application (2015-2020)
Figure 29. Global Rofecoxib Sales Market Share by Application in 2019
Figure 30. Global Rofecoxib Revenue Market Share by Application (2015-2020)
Figure 31. Global Rofecoxib Revenue Market Share by Application in 2019
Figure 32. North America Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 33. North America Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Rofecoxib Sales Market Share by Country in 2019
Figure 35. North America Rofecoxib Revenue Market Share by Country in 2019
Figure 36. U.S. Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 37. U.S. Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 39. Canada Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Rofecoxib Market Share by Type in 2019
Figure 41. North America Rofecoxib Market Share by Application in 2019
Figure 42. Europe Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 43. Europe Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Rofecoxib Sales Market Share by Country in 2019
Figure 45. Europe Rofecoxib Revenue Market Share by Country in 2019
Figure 46. Germany Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 47. Germany Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 49. France Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 51. U.K. Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 53. Italy Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 55. Russia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Rofecoxib Market Share by Type in 2019
Figure 57. Europe Rofecoxib Market Share by Application in 2019
Figure 58. Asia Pacific Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 59. Asia Pacific Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Rofecoxib Sales Market Share by Region in 2019
Figure 61. Asia Pacific Rofecoxib Revenue Market Share by Region in 2019
Figure 62. China Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 63. China Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 65. Japan Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 67. South Korea Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 69. India Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 71. Australia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 73. Taiwan Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 75. Indonesia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 77. Thailand Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 79. Malaysia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 81. Philippines Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 83. Vietnam Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Rofecoxib Market Share by Type in 2019
Figure 85. Asia Pacific Rofecoxib Market Share by Application in 2019
Figure 86. Latin America Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 87. Latin America Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Rofecoxib Sales Market Share by Country in 2019
Figure 89. Latin America Rofecoxib Revenue Market Share by Country in 2019
Figure 90. Mexico Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 91. Mexico Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 93. Brazil Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 95. Argentina Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Rofecoxib Market Share by Type in 2019
Figure 97. Latin America Rofecoxib Market Share by Application in 2019
Figure 98. Middle East and Africa Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 99. Middle East and Africa Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Rofecoxib Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Rofecoxib Revenue Market Share by Country in 2019
Figure 102. Turkey Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 103. Turkey Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 105. Saudi Arabia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 107. U.A.E Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Rofecoxib Market Share by Type in 2019
Figure 109. Middle East and Africa Rofecoxib Market Share by Application in 2019
Figure 110. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Chengdu Meinkai Chemical Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Wuhan Xinxin Jiali Biotechnology Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Tremeau Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. North America Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. Europe Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. Asia Pacific Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. Latin America Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 125. Middle East and Africa Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
1.1 Rofecoxib Product Introduction
1.2 Market Segments
1.3 Key Rofecoxib Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rofecoxib Market Size Growth Rate by Type
1.4.2 Oral Suspension.
1.4.3 Tablet-Form
1.5 Market by Application
1.5.1 Global Rofecoxib Market Size Growth Rate by Application
1.5.2 Osteoarthritis
1.5.3 Rheumatoid Arthritis
1.5.4 Juvenile Rheumatoid Arthritis
1.5.5 Acute Pain Conditions
1.5.6 Migraine
1.5.7 Dysmenorrhea
1.6 Coronavirus Disease 2019 (Covid-19): Rofecoxib Industry Impact
1.6.1 How the Covid-19 is Affecting the Rofecoxib Industry
1.6.1.1 Rofecoxib Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Rofecoxib Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Rofecoxib Market Size Estimates and Forecasts
2.1.1 Global Rofecoxib Revenue 2015-2026
2.1.2 Global Rofecoxib Sales 2015-2026
2.2 Rofecoxib Market Size by Region: 2020 Versus 2026
2.2.1 Global Rofecoxib Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Rofecoxib Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rofecoxib Competitor Landscape by Players
3.1 Rofecoxib Sales by Manufacturers
3.1.1 Rofecoxib Sales by Manufacturers (2015-2020)
3.1.2 Rofecoxib Sales Market Share by Manufacturers (2015-2020)
3.2 Rofecoxib Revenue by Manufacturers
3.2.1 Rofecoxib Revenue by Manufacturers (2015-2020)
3.2.2 Rofecoxib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rofecoxib Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rofecoxib Revenue in 2019
3.2.5 Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Rofecoxib Price by Manufacturers
3.4 Rofecoxib Manufacturing Base Distribution, Product Types
3.4.1 Rofecoxib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rofecoxib Product Type
3.4.3 Date of International Manufacturers Enter into Rofecoxib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Rofecoxib Market Size by Type (2015-2020)
4.1.1 Global Rofecoxib Sales by Type (2015-2020)
4.1.2 Global Rofecoxib Revenue by Type (2015-2020)
4.1.3 Rofecoxib Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rofecoxib Market Size Forecast by Type (2021-2026)
4.2.1 Global Rofecoxib Sales Forecast by Type (2021-2026)
4.2.2 Global Rofecoxib Revenue Forecast by Type (2021-2026)
4.2.3 Rofecoxib Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rofecoxib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Rofecoxib Market Size by Application (2015-2020)
5.1.1 Global Rofecoxib Sales by Application (2015-2020)
5.1.2 Global Rofecoxib Revenue by Application (2015-2020)
5.1.3 Rofecoxib Price by Application (2015-2020)
5.2 Rofecoxib Market Size Forecast by Application (2021-2026)
5.2.1 Global Rofecoxib Sales Forecast by Application (2021-2026)
5.2.2 Global Rofecoxib Revenue Forecast by Application (2021-2026)
5.2.3 Global Rofecoxib Price Forecast by Application (2021-2026)
6 North America
6.1 North America Rofecoxib by Country
6.1.1 North America Rofecoxib Sales by Country
6.1.2 North America Rofecoxib Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Rofecoxib Market Facts & Figures by Type
6.3 North America Rofecoxib Market Facts & Figures by Application
7 Europe
7.1 Europe Rofecoxib by Country
7.1.1 Europe Rofecoxib Sales by Country
7.1.2 Europe Rofecoxib Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rofecoxib Market Facts & Figures by Type
7.3 Europe Rofecoxib Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Rofecoxib by Region
8.1.1 Asia Pacific Rofecoxib Sales by Region
8.1.2 Asia Pacific Rofecoxib Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Rofecoxib Market Facts & Figures by Type
8.3 Asia Pacific Rofecoxib Market Facts & Figures by Application
9 Latin America
9.1 Latin America Rofecoxib by Country
9.1.1 Latin America Rofecoxib Sales by Country
9.1.2 Latin America Rofecoxib Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Rofecoxib Market Facts & Figures by Type
9.3 Central & South America Rofecoxib Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Rofecoxib by Country
10.1.1 Middle East and Africa Rofecoxib Sales by Country
10.1.2 Middle East and Africa Rofecoxib Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Rofecoxib Market Facts & Figures by Type
10.3 Middle East and Africa Rofecoxib Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Rofecoxib Products Offered
11.1.5 Merck Recent Development
11.2 Chengdu Meinkai Chemical Co. LTD
11.2.1 Chengdu Meinkai Chemical Co. LTD Corporation Information
11.2.2 Chengdu Meinkai Chemical Co. LTD Description, Business Overview and Total Revenue
11.2.3 Chengdu Meinkai Chemical Co. LTD Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Products Offered
11.2.5 Chengdu Meinkai Chemical Co. LTD Recent Development
11.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
11.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
11.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Description, Business Overview and Total Revenue
11.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Products Offered
11.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
11.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
11.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
11.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description, Business Overview and Total Revenue
11.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Products Offered
11.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description, Business Overview and Total Revenue
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Rofecoxib Products Offered
11.5.5 Pfizer Recent Development
11.6 Tremeau
11.6.1 Tremeau Corporation Information
11.6.2 Tremeau Description, Business Overview and Total Revenue
11.6.3 Tremeau Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Tremeau Rofecoxib Products Offered
11.6.5 Tremeau Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Rofecoxib Products Offered
11.1.5 Merck Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Rofecoxib Market Estimates and Projections by Region
12.1.1 Global Rofecoxib Sales Forecast by Regions 2021-2026
12.1.2 Global Rofecoxib Revenue Forecast by Regions 2021-2026
12.2 North America Rofecoxib Market Size Forecast (2021-2026)
12.2.1 North America: Rofecoxib Sales Forecast (2021-2026)
12.2.2 North America: Rofecoxib Revenue Forecast (2021-2026)
12.2.3 North America: Rofecoxib Market Size Forecast by Country (2021-2026)
12.3 Europe Rofecoxib Market Size Forecast (2021-2026)
12.3.1 Europe: Rofecoxib Sales Forecast (2021-2026)
12.3.2 Europe: Rofecoxib Revenue Forecast (2021-2026)
12.3.3 Europe: Rofecoxib Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Rofecoxib Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Rofecoxib Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Rofecoxib Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Rofecoxib Market Size Forecast by Region (2021-2026)
12.5 Latin America Rofecoxib Market Size Forecast (2021-2026)
12.5.1 Latin America: Rofecoxib Sales Forecast (2021-2026)
12.5.2 Latin America: Rofecoxib Revenue Forecast (2021-2026)
12.5.3 Latin America: Rofecoxib Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Rofecoxib Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Rofecoxib Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Rofecoxib Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Rofecoxib Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porters Five Forces Analysis
13.5 Primary Interviews with Key Rofecoxib Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rofecoxib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Table
List of Tables
Table 1. Rofecoxib Market Segments
Table 2. Ranking of Global Top Rofecoxib Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rofecoxib Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Oral Suspension.
Table 5. Major Manufacturers of Tablet-Form
Table 6. COVID-19 Impact Global Market: (Four Rofecoxib Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Rofecoxib Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Rofecoxib Players to Combat Covid-19 Impact
Table 11. Global Rofecoxib Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Rofecoxib Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Rofecoxib Sales by Regions 2015-2020 (MT)
Table 14. Global Rofecoxib Sales Market Share by Regions (2015-2020)
Table 15. Global Rofecoxib Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Rofecoxib Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Rofecoxib Sales Share by Manufacturers (2015-2020)
Table 18. Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Rofecoxib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rofecoxib as of 2019)
Table 20. Rofecoxib Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Rofecoxib Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Rofecoxib Price (2015-2020) (USD/MT)
Table 23. Rofecoxib Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Rofecoxib Product Type
Table 25. Date of International Manufacturers Enter into Rofecoxib Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Rofecoxib Sales by Type (2015-2020) (MT)
Table 28. Global Rofecoxib Sales Share by Type (2015-2020)
Table 29. Global Rofecoxib Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Rofecoxib Revenue Share by Type (2015-2020)
Table 31. Rofecoxib Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Rofecoxib Sales by Application (2015-2020) (MT)
Table 33. Global Rofecoxib Sales Share by Application (2015-2020)
Table 34. North America Rofecoxib Sales by Country (2015-2020) (MT)
Table 35. North America Rofecoxib Sales Market Share by Country (2015-2020)
Table 36. North America Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Rofecoxib Revenue Market Share by Country (2015-2020)
Table 38. North America Rofecoxib Sales by Type (2015-2020) (MT)
Table 39. North America Rofecoxib Sales Market Share by Type (2015-2020)
Table 40. North America Rofecoxib Sales by Application (2015-2020) (MT)
Table 41. North America Rofecoxib Sales Market Share by Application (2015-2020)
Table 42. Europe Rofecoxib Sales by Country (2015-2020) (MT)
Table 43. Europe Rofecoxib Sales Market Share by Country (2015-2020)
Table 44. Europe Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Rofecoxib Revenue Market Share by Country (2015-2020)
Table 46. Europe Rofecoxib Sales by Type (2015-2020) (MT)
Table 47. Europe Rofecoxib Sales Market Share by Type (2015-2020)
Table 48. Europe Rofecoxib Sales by Application (2015-2020) (MT)
Table 49. Europe Rofecoxib Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Rofecoxib Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Rofecoxib Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Rofecoxib Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Rofecoxib Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Rofecoxib Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Rofecoxib Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Rofecoxib Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Rofecoxib Sales Market Share by Application (2015-2020)
Table 58. Latin America Rofecoxib Sales by Country (2015-2020) (MT)
Table 59. Latin America Rofecoxib Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Rofecoxib Revenue Market Share by Country (2015-2020)
Table 62. Latin America Rofecoxib Sales by Type (2015-2020) (MT)
Table 63. Latin America Rofecoxib Sales Market Share by Type (2015-2020)
Table 64. Latin America Rofecoxib Sales by Application (2015-2020) (MT)
Table 65. Latin America Rofecoxib Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Rofecoxib Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Rofecoxib Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Rofecoxib Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Rofecoxib Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Rofecoxib Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Rofecoxib Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Rofecoxib Sales Market Share by Application (2015-2020)
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Chengdu Meinkai Chemical Co. LTD Corporation Information
Table 80. Chengdu Meinkai Chemical Co. LTD Description and Major Businesses
Table 81. Chengdu Meinkai Chemical Co. LTD Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Chengdu Meinkai Chemical Co. LTD Product
Table 83. Chengdu Meinkai Chemical Co. LTD Recent Development
Table 84. Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
Table 85. Wuhan Xinxin Jiali Biotechnology Co. LTD Description and Major Businesses
Table 86. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Wuhan Xinxin Jiali Biotechnology Co. LTD Product
Table 88. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
Table 89. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
Table 90. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description and Major Businesses
Table 91. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Product
Table 93. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Major Businesses
Table 96. Pfizer Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Pfizer Product
Table 98. Pfizer Recent Development
Table 99. Tremeau Corporation Information
Table 100. Tremeau Description and Major Businesses
Table 101. Tremeau Rofecoxib Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Tremeau Product
Table 103. Tremeau Recent Development
Table 104. Global Rofecoxib Sales Forecast by Regions (2021-2026) (MT)
Table 105. Global Rofecoxib Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Rofecoxib Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Rofecoxib Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Rofecoxib Sales Forecast by Country (2021-2026) (MT)
Table 109. North America: Rofecoxib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Rofecoxib Sales Forecast by Country (2021-2026) (MT)
Table 111. Europe: Rofecoxib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Rofecoxib Sales Forecast by Region (2021-2026) (MT)
Table 113. Asia Pacific: Rofecoxib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Rofecoxib Sales Forecast by Country (2021-2026) (MT)
Table 115. Latin America: Rofecoxib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Rofecoxib Sales Forecast by Country (2021-2026) (MT)
Table 117. Middle East and Africa: Rofecoxib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Rofecoxib Players
Table 122. Rofecoxib Customers List
Table 123. Rofecoxib Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Rofecoxib Product Picture
Figure 2. Global Rofecoxib Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Suspension. Product Picture
Figure 4. Tablet-Form Product Picture
Figure 5. Global Rofecoxib Sales Market Share by Application in 2020 & 2026
Figure 6. Osteoarthritis
Figure 7. Rheumatoid Arthritis
Figure 8. Juvenile Rheumatoid Arthritis
Figure 9. Acute Pain Conditions
Figure 10. Migraine
Figure 11. Dysmenorrhea
Figure 12. Rofecoxib Report Years Considered
Figure 13. Global Rofecoxib Market Size 2015-2026 (US$ Million)
Figure 14. Global Rofecoxib Sales 2015-2026 (MT)
Figure 15. Global Rofecoxib Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Rofecoxib Sales Market Share by Region (2015-2020)
Figure 17. Global Rofecoxib Sales Market Share by Region in 2019
Figure 18. Global Rofecoxib Revenue Market Share by Region (2015-2020)
Figure 19. Global Rofecoxib Revenue Market Share by Region in 2019
Figure 20. Global Rofecoxib Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Rofecoxib Revenue in 2019
Figure 22. Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Rofecoxib Sales Market Share by Type (2015-2020)
Figure 24. Global Rofecoxib Sales Market Share by Type in 2019
Figure 25. Global Rofecoxib Revenue Market Share by Type (2015-2020)
Figure 26. Global Rofecoxib Revenue Market Share by Type in 2019
Figure 27. Global Rofecoxib Market Share by Price Range (2015-2020)
Figure 28. Global Rofecoxib Sales Market Share by Application (2015-2020)
Figure 29. Global Rofecoxib Sales Market Share by Application in 2019
Figure 30. Global Rofecoxib Revenue Market Share by Application (2015-2020)
Figure 31. Global Rofecoxib Revenue Market Share by Application in 2019
Figure 32. North America Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 33. North America Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Rofecoxib Sales Market Share by Country in 2019
Figure 35. North America Rofecoxib Revenue Market Share by Country in 2019
Figure 36. U.S. Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 37. U.S. Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 39. Canada Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Rofecoxib Market Share by Type in 2019
Figure 41. North America Rofecoxib Market Share by Application in 2019
Figure 42. Europe Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 43. Europe Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Rofecoxib Sales Market Share by Country in 2019
Figure 45. Europe Rofecoxib Revenue Market Share by Country in 2019
Figure 46. Germany Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 47. Germany Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 49. France Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 51. U.K. Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 53. Italy Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 55. Russia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Rofecoxib Market Share by Type in 2019
Figure 57. Europe Rofecoxib Market Share by Application in 2019
Figure 58. Asia Pacific Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 59. Asia Pacific Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Rofecoxib Sales Market Share by Region in 2019
Figure 61. Asia Pacific Rofecoxib Revenue Market Share by Region in 2019
Figure 62. China Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 63. China Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 65. Japan Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 67. South Korea Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 69. India Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 71. Australia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 73. Taiwan Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 75. Indonesia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 77. Thailand Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 79. Malaysia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 81. Philippines Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 83. Vietnam Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Rofecoxib Market Share by Type in 2019
Figure 85. Asia Pacific Rofecoxib Market Share by Application in 2019
Figure 86. Latin America Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 87. Latin America Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Rofecoxib Sales Market Share by Country in 2019
Figure 89. Latin America Rofecoxib Revenue Market Share by Country in 2019
Figure 90. Mexico Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 91. Mexico Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 93. Brazil Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 95. Argentina Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Rofecoxib Market Share by Type in 2019
Figure 97. Latin America Rofecoxib Market Share by Application in 2019
Figure 98. Middle East and Africa Rofecoxib Sales Growth Rate 2015-2020 (MT)
Figure 99. Middle East and Africa Rofecoxib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Rofecoxib Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Rofecoxib Revenue Market Share by Country in 2019
Figure 102. Turkey Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 103. Turkey Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 105. Saudi Arabia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 107. U.A.E Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Rofecoxib Market Share by Type in 2019
Figure 109. Middle East and Africa Rofecoxib Market Share by Application in 2019
Figure 110. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Chengdu Meinkai Chemical Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Wuhan Xinxin Jiali Biotechnology Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Tremeau Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. North America Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. Europe Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. Asia Pacific Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. Latin America Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Rofecoxib Sales Growth Rate Forecast (2021-2026) (MT)
Figure 125. Middle East and Africa Rofecoxib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
-
U.S.:
-
U.K. :
-
AUS. :
-
INDIA :
